President, Northern Virginia Pathology
Pathology
Dr. Bruce A. Werness, MD
|
|
Give Review
Bruce Werness practices Pathology. He studied medicine at University of Colorado Denver School of Medicine. University of Colorado Denver School of Medicine is a one of the best medicals schools. University of Colorado Denver School of Medicine is ranked 35/8 in Research/PrimaryCare. Bruce Werness is also a published MD. He has 49 publication published. The most recent publication is: Metachronous benign solitary fibrous tumours of the pleura (localized "mesotheliomas"): a case report. Doctor Bruce A. Werness, MD accepts Medicare.
Publications
- Mucinous borderline ovarian tumors: points of general agreement and persistent controversies regarding nomenclature, diagnostic criteria, and behavior.
- Histopathology, FIGO stage, and BRCA mutation status of ovarian cancers from the Gilda Radner Familial Ovarian Cancer Registry.
- BRCA1 mutations.
- Endometrial carcinoma cells are nonpermissive for CD44-erbB2 interactions.
- Transitional cell ovarian carcinoma in a BRCA1 mutation carrier.
- Expression of CD44S and CD44v5 is more common in stage III than in stage I serous ovarian carcinomas.
- CD44 mediates constitutive type I receptor signaling in cervical carcinoma cells.
- Familial ovarian cancer and early ovarian cancer: biologic, pathologic, and clinical features.
- Identification of a novel 9 cM deletion unit on chromosome 6q23-24 in papillary serous carcinoma of the peritoneum.
- Histopathology of familial ovarian tumors in women from families with and without germline BRCA1 mutations.
- Primary ovarian dysgerminoma in a patient with a germline BRCA1 mutation.
- Comparative study of ovarian cancer histopathology by registry pathologists and referral pathologists: a study by the Gilda Radner Familial Ovarian Cancer Registry.
- Ovarian carcinoma in situ with germline BRCA1 mutation and loss of heterozygosity at BRCA1 and TP53.
- Malignant peripheral nerve sheath tumors of the head and neck: analysis of prognostic factors.
- Ovarian dysplasia identified by cul-de-sac aspiration: a reexamination of previously reported cases.
- Mutation analysis of BRCA1, TP53, and KRAS2 in ovarian and related pelvic tumors.
- Prognostic significance of p53 and p21(waf1/cip1) immunoreactivity in epithelial cancers of the ovary.
- p53, c-erbB, and Ki-67 expression in ovaries removed prophylactically from women with a family history of ovarian cancer.
- HER-2/neu oncogene amplification in stage I and stage III ovarian papillary serous carcinoma.
- Expression of the hyaluronan receptor, CD44S, in epithelial ovarian cancer is an independent predictor of survival.
- Paradoxical correlations of cyclin-dependent kinase inhibitors p21waf1/cip1 and p27kip1 in metastatic colorectal carcinoma.
- Trisomy 8 in stage I and stage III ovarian cancer detected by fluorescence in situ hybridization.
- Altered surface and cyst epithelium of ovaries removed prophylactically from women with a family history of ovarian cancer.
- Metachronous benign solitary fibrous tumours of the pleura (localized "mesotheliomas"): a case report.
- Prognostic factors in extraovarian primary peritoneal carcinoma.
- Mutations in BRCA1 from fixed, paraffin-embedded tissue can be artifacts of preservation.
- Correlation of TP53 mutations and p53 expression in ovarian tumors.
- Importance of lymph node metastases in primary peritoneal carcinoma.
- HsMCM2/BM28: a novel proliferation marker for human tumors and normal tissues.
- Tumor of the broad ligament in von Hippel-Lindau disease of probable mullerian origin.
- Primary peritoneal adenocarcinoma metastatic to the brain.
- Activation of the focal adhesion kinase signal transduction pathway in cervical carcinoma cell lines and human genital epithelial cells immortalized with human papillo...
- Telomerase activity in benign and malignant thyroid tumors.
- p53-independent expression of p21waf1/cip1 in preinvasive and invasive squamous neoplasms of the uterine cervix.
- Identical, unique p53 mutations in a primary ovarian mucinous adenocarcinoma and a synchronous contralateral ovarian mucinous tumor of low malignant potential suggest ...
- Expression of the p53 induced tumor suppressor p21waf1/cip1 in ovarian carcinomas: correlation with p53 and Ki-67 immunohistochemistry.
- Luteinized thecoma with sclerosing peritonitis.
- Combining cervical and anal-canal specimens for gonorrhea on a single culture plate.
- Lack of utility of a Limulus amoebocyte lysate assay in the diagnosis of urethral discharges in men.
- Molecular mechanisms of transformation by the human papillomaviruses.
- Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product.
- Cytopathology of sexually transmitted disease.
- Genital human papillomavirus infections.
- The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53.
- Association of human papillomavirus types 16 and 18 E6 proteins with p53.
- Role of the human papillomavirus oncoproteins in transformation and carcinogenic progression.
- Proficiency testing in gynecologic cytology.
- BRCA1/2 mutation status influences somatic genetic progression in inherited and sporadic epithelial ovarian cancer cases.
Schools
UNIVERSITY OF COLORADO AT DENVER
University Of Colorado Health Sciences Center
University Of Colorado
National Cancer Institute
Doctors Specialties
- Pathology
Accepted Insurances
- Choice Plus POS II
- Amerigroup (Wellpoint)
- Blue Cross Blue Shield
- Cigna
- Commercial Insurance Company
- CoreSource
- Coventry Health Care
- EBS-RMSCO
- Harvard Pilgrim Health Care PPO
- HealthSmart
- Humana
- Mail Handlers Benefit Plan (MHBP)
- Medicaid
- Medicare MCR
- Meritain Health
- MultiPlan
- POMCO Group
- Providence Health Plans
- Simplifi
- Tufts Health Plans
- UniCare
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
- Wells Fargo Insurance
Education
-
National Institutes of Health Clinical Center -
University of Colorado -
University of Colorado Denver School of Medicine
Hospital
-
Inova Fairfax Hospital -
Inova Mount Vernon Hospital -
Inova Fair Oaks Hospital
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1336103464 |
| Last Name Of The Provider | WERNESS |
| First Name Of The Provider | BRUCE |
| View All |
Similar Doctors
|
|
Dr. Tuyethoa N. Vinh, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gerald D. Willett, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steven J. Gauerke, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Barry M. Shmookler, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ginine M. Beyer, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Joon H. Park, MD
This Doctor is OpenDoctor Recommended.
|